Castle Biosciences (CSTL) Interest Coverage Ratio Growth (1y) (2019 - 2026)
Castle Biosciences (CSTL) Interest Coverage Ratio Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 14.65% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 3.80% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | -91.18% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 120.45% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | -7.61% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 97.40% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | -28.45% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | -11.26% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 10.67% |
| 10 | Castle Biosciences | 926.56 Mn | 659.75 Mn | 79.85 Mn | 99.81% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 99.81% |
| Mar 31, 2026 | 99.88% |
| Dec 31, 2025 | -166.46% |
| Sep 30, 2025 | -103.01% |
| Jun 30, 2025 | -102.42% |
| Mar 31, 2025 | -260.33% |
| Dec 31, 2024 | 100.07% |
| Sep 30, 2024 | 1,957.67% |
| Jun 30, 2024 | 697.72% |
| Mar 31, 2024 | 94.21% |
| Dec 31, 2023 | -15,635.94% |
| Sep 30, 2023 | 2.22% |
| Jun 30, 2023 | -1,103.81% |
| Mar 31, 2023 | -1,549,963.11% |
| Dec 31, 2022 | 99.88% |
| Sep 30, 2022 | -1,131.51% |
| Jun 30, 2022 | -377.19% |
| Mar 31, 2022 | -1,348.02% |
| Dec 31, 2021 | -197,543.30% |
| Sep 30, 2021 | -158.89% |